nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv qikanlogo popupnotification paper paperNew
2025, 02, v.19 675-679
阵发性心房颤动华法林抗血栓治疗时采取风险护理的价值分析
基金项目(Foundation):
邮箱(Email):
DOI: 10.20256/j.cnki.zgdxbl.20250701.003
摘要:

目的 探讨风险护理应用于使用华法林抗凝治疗的阵发性心房颤动(paroxysmal auricular fibrillation,PAF)患者的价值。方法 选择2023年1月—2024年12月天津医科大学附属宝坻医院就诊并接受华法林抗凝的62例PAF患者,信封法随机分为对照组和研究组,各31例,两组华法林使用信息相同。其中对照组提供常规护理,研究组予以常规护理联合风险护理,比较两组华法林使用情况[国际标准化比值(international nor-malized ratio,INR)处于目标范围内的时间百分比(time in therapeutic range,TTR)、定期监测INR占比等]、血栓栓塞发生率及出血事件(皮下出血、牙龈出血等)发生率等。结果 研究组TTR高于对照组(t=7.395,P<0.001),定期监测INR占比(96.77%)高于对照组(74.19%)(χ2=6.369,P=0.012);血栓栓塞发生率(0)显著低于对照组(19.35%)(χ2=6.643,P=0.010);牙龈出血、黏膜出血发生率均低于对照组(χ2=8.434、6.613,P=0.004、0.010);两组消化道出血、皮下出血发生率对比,无统计学意义(χ2=1.449、0.350,P=0.229、0.554)。结论 针对使用华法林抗凝的PAF患者实施风险护理有效性、安全性均较优,有利于提高TTR及定期监测INR占比,同时能够有效降低血栓栓塞、出血事件发生率。

Abstract:

Objective To explore the value of risk nursing in patients with paroxysmal atrial fibrillation(PAF)treated with warfarin anticoagulation therapy. Methods 62 patients with PAF who received warfarin anticoagulation at Baodi Hospital affiliated to Tianjin Medical University from January 2023 to December 2024were selected. They were randomly divided into a control group and a study group using envelope method, with 31 patients in each group. The warfarin use information was the same in both groups. The control group received routine care, while the study group received routine care combined with risk care. The use of warfarin between the two groups was compared, including the percentage of time in therapeutic range(TTR)when the international normalized ratio(INR)was within the target range, the proportion of INR monitored regularly, the incidence of thromboembolism, and the incidence of bleeding events(subcutaneous bleeding, gingival bleeding, etc.). The TTR of the study group was higher than that of the control group(t=7.395,P<0.001), and the proportion of INR monitored regularly(96.77%)was higher than that of the control group(74.19%)(χ2=6.369,P=0.012);The incidence of thromboembolism(0)was significantly lower than that of the control group(19.35%)(χ2=6.643,P=0.010); The incidence of gingival bleeding and mucosal bleeding was lower in the control group than in the control group(χ2=8.434、6.613,P=0.004、0.010); There was no statistically significant difference in the incidence of gastrointestinal bleeding and subcutaneous bleeding between the two groups (χ2=1.449、0.350,P=0.229、0.554). Conclusion The implementation of risk nursing for PAF patients using warfarin anticoagulation is effective and safe, which is beneficial for improving TTR and regularly monitoring the proportion of INR. At the same time, it can effectively reduce the incidence of thromboembolism and bleeding events.

参考文献

[1]伍焕平,丁倩,王景浩,等.阵发性心房颤动患者P波指数与左心房/左心耳血栓形成的相关性分析[J].中国心血管病研究,2025,23(1):9-14.

[2]裴小锐,顾梅,张振蔚.利伐沙班与华法林对老年非瓣膜病心房颤动合并肾功能不全的疗效[J].西北药学杂志,2024,39(4):116-120.

[3]贾秋蕾,杨亦含,胡元会,等.阵发性心房颤动进展为持续性心房颤动的危险因素分析[J].中国循证心血管医学杂志,2024,16(7):834-836,849.

[4]中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.心房颤动基层诊疗指南(2019年)[J].中华全科医师杂志,2020,19(6):465-473.

[5]廖丽红,刘甲兴,傅懋林.隐源性脑卒中合并阵发性心房颤动病人P波最大时限和P波离散度的临床意义[J].中西医结合心脑血管病杂志,2022,20(24):4588-4591.

[6]杨永全,张彩霞,刘志广.瑞舒伐他汀钙片联合胺碘酮及华法林治疗阵发性房颤的效果观察[J].中国实用医刊,2022,49(3):112-115.

[7]刘恩香,刘晓晨,李晶晶,等. IGF-1与IGFBP-3对阵发性心房颤动射频消融术后复发的预测价值[J].中西医结合心脑血管病杂志,2024,22(17):3210-3214.

[8]林德奇,黄开建.替米沙坦联合华法林钠片对原发性高血压伴阵发性心房颤动患者的影响[J].中外医学研究,2022,20(23):5-9.

[9]陈云,江雅,陈妙霞,等.基于风险预警系统理论的护理风险层级管理体系构建及应用[J].现代临床护理,2022,21(4):60-65.

[10]贾真,李小雪,王曼,等.风险护理联合精细化护理在神经外科术后患者中的应用[J].齐鲁护理杂志,2024,30(8):89-91.

[11]胡秀媚,冯亦兴,崔衬娟,等.阵发性心房颤动华法林抗血栓治疗采取风险护理对心功能的改善效果观察[J].基层医学论坛,2023,27(12):25-27.

[12]王燕,龚蕾蕾,赵蒙.风险护理策略联合健康教育对肺癌患者的影响[J].中外医学研究,2025,23(1):75-79.

基本信息:

DOI:10.20256/j.cnki.zgdxbl.20250701.003

中图分类号:R473.5

引用信息:

[1]王曼曼,李爱学.阵发性心房颤动华法林抗血栓治疗时采取风险护理的价值分析[J].中国典型病例大全,2025,19(02):675-679.DOI:10.20256/j.cnki.zgdxbl.20250701.003.

基金信息:

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文